drugset / Trial / NCT04451291
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
NaSingle-groupOpen-labelTreatment
Summary
This is a research study to see how safe and effective decidual stromal cells are in treating patients with respiratory failure (breathing problem where not enough oxygen is passed from the lungs into the blood) caused by COVID-19.
Timeline
- Start
- 2020-09-25
- Primary completion
- 2023-11-07
- Completion
- 2023-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decidual Stromal Cells | Cell therapy | 1e+06 cells/kg | — |